Zucara Therapeutics Company

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type 1 diabetes is not properly controlled. It has demonstrated potential to specifically block somatostatin type 2 receptors in the pancreas thereby preventing hypoglycemia and restoring natural glucose levels in the blood. Zucara’s method offers a clear advantage to patients as a preventative measure whereas current drug therapies can only rescue a patient already experiencing potentially dangerous low blood sugar.
Industry: Geroscience
Headquarters: Vancouver, British Columbia, Canada
Zip: 1-10
Founded Date: 2015-01-01
Employees Number: 1-10
Acquisitions Number: 9
Investors Number: 26807893
Total Funding: 26807893
Last Funding Date: Grant
Last Funding Type: Grant

Visit Website
https://twitter.com/zucara_ca
https://www.crunchbase.com/organization/zucara-therapeutics
Register and Claim Ownership